What's it like to live with ADHD or dyslexia or know how a neurodivergent friend actually feels in their mind-not just the textbook definitions, but the day-to-day emotional rollercoaster? In Chris Packham’s groundbreaking new documentary, Inside Our ADHD Minds, we’re invited into the lives of Henry and Jo, two individuals navigating the invisible yet overwhelming terrain of neurodivergence.
Henry, a vibrant tour guide in Soho, speaks with honesty about forgetting to eat, losing track of time, and the deep fear that even those closest to him don’t truly understand who he is. Then there’s Jo, whose story hits a different chord. After 14 career changes and years of being labeled “too much,” it took her daughter’s comment to spark the realization that ADHD might have been part of her life story all along.
What follows in the documentary is not just awareness it’s a revelation. With stunning personal films, expert insights, and Chris Packham’s own neurodivergent lens guiding the way, Inside Our ADHD Minds dismantles stereotypes and replaces them with empathy, clarity, and humanity. This isn’t just about attention or hyperactivity it’s about identity, grief, resilience, and the need to be truly seen.
the two-part documentary series offers an emotionally intelligent and deeply personal exploration into the minds of individuals living with ADHD and dyslexia. It’s a follow-up to Packham’s earlier acclaimed project, Inside Our Autistic Minds, and again leans into empathy, science, and storytelling to deepen public understanding of neurodivergence.
As rates of ADHD and dyslexia diagnoses rise globally, especially among women and adults, Packham’s series couldn’t be more timely. But unlike dry medical overviews, this is narrative-driven, first-person neurodivergence—seen through the eyes of those who live it. From chaotic inner worlds to coping mechanisms that go unnoticed, here are the seven most compelling takeaways from Inside Our ADHD Minds—and what they reveal about the realities of neurodiverse thinking.
One of the first myths the documentary busts is right there in the name: “attention deficit hyperactivity disorder.” As Packham candidly explains while walking through the woods—a signature format in the series—ADHD is not about lacking attention. It's about struggling to control and regulate it. One expert likens it to having six televisions on in your brain, all blaring at once, with no remote control.
This reframing is important. People with ADHD don’t lack focus—they often focus too much, too intensely, or on the “wrong” thing from a neurotypical perspective. Recognizing this nuance allows for more compassionate, functional approaches to support and treatment.
A vital theme running through the series is the gendered nature of neurodivergence diagnosis. While ADHD has historically been associated with hyperactive boys in classrooms, Packham interviews experts who explain how girls—like Jo, one of the documentary’s protagonists—often display symptoms differently. They may internalize their restlessness, mask their distress, or be mislabeled as emotional, disorganized, or lazy.
This misrecognition delays diagnosis, sometimes for decades. Jo wasn’t diagnosed until adulthood, after navigating 14 careers and hitting emotional and professional burnout. Her journey reflects a broader issue: ADHD and dyslexia in women are under-diagnosed, under-researched, and misunderstood—something healthcare systems globally must address.
Perhaps the most powerful element of the documentary is the way it allows neurodivergent individuals to represent themselves. Both Jo and Henry, the two central figures with ADHD, are given the opportunity to make short films to express what their minds feel like from the inside.
Henry’s film is a chaotic collage of missed alarms, cluttered thoughts, and forgotten meals—offering his family a visceral insight into why even small daily tasks can feel overwhelming. Jo’s story is more emotional, showing the grief she carries for the person she might have become if she had been diagnosed earlier.
These segments remind us that self-expression and creative agency are critical tools for mental health and healing. They can bridge the chasm between external behavior and internal reality in ways clinical language cannot.
In the second episode, Packham shifts the lens to dyslexia—a learning difference that affects up to 10% of the population. While commonly associated with reading difficulties, the documentary underscores the broader cognitive landscape of dyslexia: challenges with time management, memory, verbal expression, and navigation.
One striking insight comes from the lived experience of Packham’s stepdaughter, Megan McCubbin, who was told by a teacher that she would never succeed in science due to her dyslexia. Today, she holds a degree in zoology. Her story is a testament to the fact that neurodivergence often coexists with creativity, adaptability, and resilience—not deficiency.
A subtle but crucial theme throughout the series is the sheer exhaustion of navigating a world not built for you. Dyslexic individuals often expend extraordinary energy simply trying to remember appointments, organize their day, or communicate clearly. ADHD minds, bombarded by sensory input and interrupted thoughts, can find even simple decisions emotionally taxing.
This cognitive labor takes a toll. Many neurodivergent individuals live with chronic fatigue, which further exacerbates symptoms and can lead to a cycle of self-blame and burnout.
Both Jo and Henry try medication as part of their ADHD management—but with mixed results. Henry, diagnosed during his school years, disliked how the medication made him feel. Jo, however, found relief. This mirrors real-world experiences: medication can be life-changing for some, while others prefer alternative or supplemental strategies like cognitive behavioral therapy, coaching, and lifestyle modifications.
The documentary handles this with grace—there’s no agenda or judgment, only individual stories and honest reflection. It’s a reminder that treatment for neurodivergent conditions must be personalized and patient-centered.
Ultimately, Inside Our ADHD Minds is about asking for understanding, not solutions. Henry isn’t asking his parents to change him. Jo isn’t looking for retroactive pity. What both seem to want is acknowledgment: “This is how I operate, and I’m okay.”
This message lands at a time when the neurodiversity movement is gaining traction globally—from classrooms in the U.S. to boardrooms in Europe and universities in Asia. Creating truly inclusive societies means moving beyond awareness to acceptance and adaptation.
As Chris Packham himself notes, “By better understanding neurodivergent people’s lived experiences, we can help remove barriers to their success.”
And that’s the real takeaway here: empathy, not diagnosis, is the first step toward meaningful support.
Heart disease remains one of the leading causes of death globally, and while technology has evolved to the point where predicting heart attacks is possible, the medical world still struggles to put this into practice. Experts point to both promise and pitfalls in predictive cardiology, revealing why such life-saving tech is not yet a mainstream reality.
Dr. Vikrant B. Khese, Cardiologist at Jehangir Hospital, Pune, says the idea that we can predict heart attacks before they happen is both “exciting and frustrating, because while the technology exists, its real-world implementation remains limited.”
He explains that artificial intelligence (AI) and machine learning (ML) have incredible potential in this field. These tools can analyse vast datasets, such as blood pressure, lipid profiles, ECGs, imaging, and even genetic markers, to uncover patterns that might be invisible to the human eye. “These tools can detect subtle risk factors that may be missed in routine clinical practice. However, several challenges continue to hold us back,” he says.
One of the biggest concerns is the source of the data feeding these algorithms. “The majority of AI models are trained on Western datasets that do not reflect the unique genetic, environmental, and lifestyle factors of Indian or Asian populations. This creates a mismatch, resulting in lower accuracy and reliability for non-Western patients.”
Dr. Khese adds that cardiovascular disease is deeply multifactorial. It is not just about clinical metrics. “Stress, socioeconomic status, cultural diet patterns, air pollution, and unstructured physical activity all influence risk but are difficult to quantify in a dataset. AI still struggles with these intangible but crucial variables.”
And even when predictive tools are developed, another hurdle lies in the healthcare system’s ability to use them. “Data-driven predictions can only be as good as the data input. In India, inconsistent electronic medical records, underreporting, and fragmented healthcare systems make it harder to gather high-quality longitudinal data, limiting the AI's learning potential.”
Crucially, there is also a behavioural gap. “Even when prediction tools exist, they are not routinely used by clinicians due to scepticism, lack of training, or workflow disruption. Bridging the gap between innovation and implementation is a major hurdle.”
According to Dr. Khese, technology must complement clinical judgement, not replace it. “AI is a powerful tool but not a standalone solution. Until we combine high-quality, representative data with clinical wisdom and system-level integration, the promise of predicting heart attacks before they happen will remain underutilised. The future lies in synergy; technology must empower doctors, not replace them.”
Dr. Vijay D'Silva, Medical Director of White Lotus International Hospital and Clinical Advisor and Mentor of Heartnet India, backs this view and draws attention to major international trials. “Research from the University of Oxford has suggested that a global trial of an AI tool that can predict the 10-year risk of heart attack has shown that in about 45 per cent of patients with chest pain, treatment could be improved,” he shares.
“Early detection of cardiac risk allows timely treatment and monitoring that can help reduce the mortality rate,” he says, explaining that most coronary blockages are asymptomatic. “Some present with chest, arm or jaw pain on exertion (angina pectoris). Few present as a heart attack or sudden death. People seek treatment after a heart attack when the damage is already done.”
According to Dr. D’silva, “With the help of the right tools, it is now possible to predict a heart attack before it occurs.” Among these tools are blood tests, ECGs, and advanced risk calculators such as the AHA PREVENT calculator, ASCVD Risk Calculator Plus, QRISK3, and SCORE2.
He points out how the 2023 AHA PREVENT calculator estimates 10-year cardiovascular risk in individuals aged 30 to 79, and 30-year risk in adults aged 30 to 59. “Early-stage detection of CVD minimises the cost and also reduces the CVD mortality rate,” he says.
This tool divides patients into four risk categories, each with its own treatment strategy:
Despite these advances, Dr D'Silva says, “The gap lies in implementation. Most people still wait for the symptoms to appear before seeing a doctor. Heart attacks, unfortunately, strike without any warning, especially in women and younger patients, where symptoms can be atypical.”
He stresses that predictive cardiology is not yet standard in clinical practice. “People who are at risk seek care when symptoms arise. But in cardiology, symptoms often come too late. Up to 50 per cent of heart attack victims had no prior warning signs.”
Dr. D'silva concludes, “The ability to predict heart attacks is advancing continuously, but we need public awareness and equitable access to make predictive cardiology more standard.”
In short, we can predict heart att but until we normalise risk screening, improve data systems, and bridge the clinical gap, too many heart attacks will continue to catch people and systems off guard.
When strands clog your shower drain or your brush looks full every time you run it through your hair, panic is a natural response. Hair loss, or alopecia, is not just a cosmetic concern; it often hints at something deeper. And yet, thanks to internet half-truths and old wives’ tales, myths about alopecia spread faster than a viral meme. On World Alopecia Day, we turn to experts to separate fact from fiction while spotlighting the hidden medical conditions that might be behind the hair fall.
The good news? “Early diagnosis and treatment of these conditions can help restore hair growth and prevent permanent damage,” he assures.
Myth 1: “Only men experience alopecia.”
“While male pattern baldness is more commonly discussed, women are equally susceptible to alopecia due to hormonal imbalances, thyroid issues, and nutritional deficiencies,” says Dr Gangurde. Yes, ladies lose hair too and not just from brushing too hard.
Myth 2: “Stress alone is responsible for hair loss.”
While stress is definitely not good for your scalp’s health, it is not the lone cause. “Alopecia usually has multiple triggers, including genetics, autoimmune conditions, and underlying medical issues,” explains Dr Gangurde. Translation: stressing about stress causing hair fall might make things worse.
Myth 3: “Alopecia is always permanent and untreatable.”
This one might be the most damaging myth of all. “Many forms of hair loss, especially those caused by hormonal or nutritional factors, are reversible with timely medical intervention,” says Dr Gangurde. PRP therapy, medications, and lifestyle changes can all turn things around if you act early enough.
Do Not Just Shed Tears, Seek Help
If your hair has been thinning or falling out in clumps, resist the urge to DIY it with oils, serums, or social media hacks. “If you experience sudden or persistent hair loss, consult a dermatologist or trichologist promptly,” advises Dr Gangurde. “Early intervention can address the root cause, prevent progression, and in many cases, restore healthy hair growth.” Remember that alopecia is not just a surface-level issue. And with the right diagnosis, it is often more fixable than you think.
Credits: Canva
The 2025 flu season has turned out to be unlike any other in recent memory. This year, the flu season is marked by record-setting infections, multiple viral peaks, vaccine mismatches, and an overstretched healthcare system.
According to the Centers for Disease Control and Prevention (CDC), this year’s influenza activity is the most intense since the 2009 swine flu pandemic, with over 80 million estimated illnesses and rising. What’s driving this intensity, and what should the public know about prevention and symptom management?
Let’s break down what makes this flu season so severe and what it means for your health.
In most years, flu activity in the U.S. typically follows a predictable pattern, starting in October, peaking between December and February, and fading by April. But the 2024–2025 season has defied that rhythm.
Cases surged past the national baseline in December and then, unexpectedly, peaked again in February, a second wave that blindsided doctors and public health experts.
As of March 2025, the CDC had reported an estimated 37 million influenza infections, 480,000 hospitalizations, and 21,000 deaths. Hospitalizations, in fact, reached their highest levels in 15 years.
One key driver? A mismatch between circulating flu strains and this year’s vaccine. The dominant strains: H1N1 and H3N2, accounted for more than 99% of cases.
H3N2, in particular, is known for mutating quickly and evading immune responses, and only about half of circulating H3N2 samples matched well with vaccine antibodies, according to CDC surveillance data.
Another reason this year’s flu is hitting so hard: our immune systems are still catching up.
During the height of the COVID-19 pandemic, widespread masking, social distancing, and school closures suppressed not just SARS-CoV-2 but also seasonal flu and other common respiratory viruses. While that helped in the short term, it reduced community-level immunity over time, especially among children, who typically build natural resistance through repeated exposures.
“Young children who were toddlers or preschoolers during the pandemic missed early exposures to flu viruses,” explained experts at the nonprofit group Families Fighting Flu. “Now they’re in school, more socially active, and more vulnerable.”
The CDC reported a troubling spike in pediatric flu deaths this season with 216 fatalities, making it the deadliest flu season for children outside of a pandemic year. Neurological complications such as seizures and hallucinations also rose among young patients.
Another unusual trend: COVID-19 has taken a back seat this winter
Unlike previous years when COVID-19 variants dominated respiratory illness charts, flu has surged ahead as the top driver of doctor visits and hospitalizations. This could be due to a shift in viral dominance, changing weather patterns, or differences in immunity buildup. According to the CDC, nearly 8% of all outpatient visits are currently for flu-like symptoms, much higher than what’s typical for this time of year.
Vaccine Fatigue and Gaps in Coverage
Vaccination remains the strongest tool we have to fight influenza, but uptake has been stagnant, or worse, declining, in key groups.
As of April 2025:
Barriers like vaccine hesitancy, misinformation, racial and ethnic disparities in healthcare access, and fewer flu shot clinics in rural areas continue to widen the gap.
The 2025 flu has shown typical but often more intense symptoms than in previous years. Here’s what to look out for:
These symptoms may overlap with COVID-19 or RSV, but tend to come on faster and hit harder in flu cases this season.
For most healthy people, flu symptoms begin 1 to 4 days after exposure and typically last about 5 to 7 days. However, fatigue and cough may linger for up to two weeks.
You’re considered most contagious in the first 3 to 4 days after symptoms start but can continue to spread the virus up to a week later. The CDC recommends staying home until you’ve been fever-free for at least 24 hours without medication.
Vaccinated individuals may experience milder or shorter symptoms, but those with underlying conditions, young children, and older adults may have longer recoveries and higher risk of complications.
Yes, especially in people with weakened immune systems, chronic illnesses, or no prior flu immunity.
Possible complications include:
This is why experts stress that prevention remains the best medicine.
Here’s how to lower your risk during the remainder of the 2025 season:
© 2024 Bennett, Coleman & Company Limited